After detox, depression, anxiety, or other mood symptoms may continue. Clinicians may need time to determine whether symptoms are related to substance use, reflect a co-occurring condition, or both. This article focuses on reassessing those conditions in patients stable enough to participate in addiction treatment.
Detox is a transition point, not a diagnostic finish line.
Depression, anxiety, irritability, sleep disruption, and changes in concentration can occur during withdrawal and early recovery. They may also reflect a co-occurring mood or anxiety disorder, a medical condition, medication effects, or several factors at once. It can be difficult to identify the cause from one evaluation.
For clinicians treating addiction alongside stable co-occurring mood or anxiety disorders, the task is to assess acuity, establish a working formulation, and track how symptoms change as the patient stabilizes. The same diagnostic question arises with substance-induced mood disorder and substance-induced anxiety disorder, where symptoms can resemble independent depression or anxiety.
Assess safety & acuity first.
Before proceeding with addiction treatment, assess immediate safety and determine whether urgent psychiatric or medical evaluation is needed. Acute psychosis, mania, imminent suicide risk, severe agitation, confusion, or inability to meet basic needs may require stabilization at a higher level of care. These acute presentations are outside the population this article—and Enterhealth’s addiction programs—are intended to address.
The ASAM hospital and emergency department implementation guide recommends screening for and stabilizing co-occurring psychiatric conditions, including suicide risk, while addressing the substance use disorder. This parallel approach matters when symptoms themselves interfere with engagement, safety, or participation in treatment.
Build a timeline before settling on a diagnosis.
A careful timeline often provides more diagnostic value than the first symptom checklist. Document the substances used, pattern and amount of use, route, last use, withdrawal course, periods of abstinence, prescribed and nonprescribed medications, and the timing of each symptom. Ask whether symptoms began before heavy substance use, emerged during intoxication or withdrawal, improved during prior periods of abstinence, or recurred when the patient was not using.
When available and appropriate, review prior treatment records and seek collateral history with the patient’s consent. Family psychiatric history, previous diagnoses, medication response, trauma history, baseline functioning, and recent changes in sleep and cognition can add context. No single detail proves that symptoms are substance-induced or independent, but the pattern across time can strengthen or weaken each possibility.
Use abstinence as information, not as a reason to withhold care.
Symptoms related to intoxication or withdrawal often improve as the acute effects resolve, but the course varies by substance, duration and severity of use, co-occurring conditions, and individual factors. SAMHSA’s TIP 42 guidance on substance-induced and independent mental disorders describes these diagnoses as provisional in many cases and recommends observing symptom changes and reevaluating over time. It also cautions clinicians not to withhold nonmedication treatment while the origin of symptoms remains unclear.
The diagnostic framework discussed in TIP 42 identifies persistence for a substantial period after acute withdrawal or severe intoxication, such as a month, as one piece of evidence that may favor an independent disorder. That example is not a universal waiting rule. It should not be used to postpone treatment, defer a safety assessment, or require every patient to complete a fixed period of abstinence before receiving psychiatric care.
A substance-induced diagnosis also does not rule out a separate co-occurring condition. Patients can have both, and the working formulation may change as more history becomes available. Document what is known, what remains uncertain, and when the next reassessment will occur.
Reassess mood and anxiety symptoms over time.
Continued evaluation may be appropriate when depression, anxiety, sleep problems, or mood symptoms predate heavy substance use, persist or worsen as withdrawal resolves, recur during abstinence, or substantially affect daily functioning. These signs don’t establish a diagnosis by themselves, but they may indicate a co-occurring condition that needs ongoing care.
Treat current symptoms while the formulation develops.
For patients stable enough to participate in addiction treatment, support does not have to wait for a final psychiatric diagnosis. Continue substance use treatment alongside appropriate care for co-occurring depression, anxiety, or stable bipolar disorder, with consultation or referral when symptoms fall outside the program’s scope.
At follow-up, reassess symptom severity, functioning, sleep, cognition, substance use, medication effects, and safety. Update the formulation when the evidence changes, and coordinate handoffs so the next clinician understands both the immediate plan and the unresolved diagnostic questions. Reassessment is part of treating co-occurring disorders, not a sign that the initial assessment failed.
A clearer picture can emerge with time and coordinated care.
When psychiatric symptoms persist after detox, clinicians do not have to choose between dismissing them as withdrawal and declaring a primary disorder too early. A longitudinal approach can make room for both careful diagnosis and timely care: stabilize risk, understand the patient’s history, treat what is affecting them now, and reassess as recovery progresses.
How Enterhealth supports patients with co-occurring needs.
Enterhealth treats addiction alongside co-occurring conditions such as depression, anxiety, and bipolar disorder when they can be safely managed within the patient’s treatment plan. Residential and outpatient care include medical assessment, psychiatric evaluation, medication management, and ongoing support as recovery progresses. Patients experiencing an acute psychiatric crisis or psychosis requiring specialty stabilization need a higher level of psychiatric care.
For clinicians considering treatment for a patient with a substance use disorder and stable depression, anxiety, or bipolar disorder, contact Enterhealth’s team to discuss whether residential or outpatient care may be a fit.


